Page last updated: 2024-09-03

mci 154 and olprinone

mci 154 has been researched along with olprinone in 1 studies

Compound Research Comparison

Studies
(mci 154)
Trials
(mci 154)
Recent Studies (post-2010)
(mci 154)
Studies
(olprinone)
Trials
(olprinone)
Recent Studies (post-2010) (olprinone)
65101572543

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hata, K; Hayashi, Y; Mori, M; Takaoka, H; Takeuchi, M; Yamaguchi, K; Yamakawa, H; Yokoyama, M1

Other Studies

1 other study(ies) available for mci 154 and olprinone

ArticleYear
Beneficial effects of a Ca2+ sensitizer, MCI-154, on the myocardial oxygen consumption-cardiac output relation in patients with left ventricular dysfunction after myocardial infarction: comparison with dobutamine and phosphodiesterase inhibitor.
    American heart journal, 1997, Volume: 133, Issue:3

    Topics: Cardiac Output; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Hemodynamics; Humans; Imidazoles; Myocardial Infarction; Oxygen Consumption; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Ventricular Dysfunction, Left

1997